Atlas Trials

DP-R213 Phase 1 Pharmacokinetics Study

Clinical trial NCT03010267 · COMPLETED

Trial details

NCT number
NCT03010267
Sponsor
Alvogen Korea
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2017-01-03
Primary completion
2017-03-08
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.